Rare
lephants
Screener
Toggle theme
NewAmsterdam Pharma Company N.V.
NAMS
·
Healthcare, Drug Manufacturers - General, Netherlands
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
Sales Per Share
Compare
←
5Y
10Y
MAX
→
Sales Per Share
Chart
Table
Fiscal Year
Sales Per Share
FY2023
$0.17
FY2024
$0.48
FY2025
$0.19
Download CSV
